"Dating agency" boosts hunt for disease genes

Doctors and scientists nationwide will today for the first time be able to join together over the internet to start the search for genes that underlie a range of chronic diseases.


Patients across Britain with cancer, heart and other common diseases have been providing blood samples for research since 2000. They are part of a project hosted by The University of Manchester that will allow more researchers than ever before to study genes in chronic diseases. The project – called the UK DNA Banking Network – was initiated in 1999 as a scientific infrastructure with government funding via the Medical Research Council.

“The infrastructure is already up and running for handling patient samples. Now what we’ve done is to create a sort of scientists’ dating agency and shop,” explains the Director of the Network’s archive, Dr Martin Yuille (University of Manchester). “Vetted scientists can find on the website both data and materials about a disease. Then, they can ’date’ a collaborator, design an experiment together and make an online wish list of patients’ DNAs that they need.”

The DNA Network provides web access by registered researchers to detailed summaries of data on patients whose anonymity is assured. The researchers hone their hypotheses in collaboration with the clinicians who are the custodians of the samples provided by patients. The new collaborators then request top quality research materials from the DNA Network’s archive.

“The significance of this development is that it builds on the success of the Human Genome Project. This discovered all our genes – and revealed that biologists now need serious logistics for this type of research,” says Dr Yuille. “The UK DNA Banking Network is leading the world in providing a sample and data infrastructure to tackle the challenge of uncovering the genetic pathways of complex disease.”

Dr Kate Dixon, who manages the archive at the Centre for Integrated Genomic Medical Research (CIGMR) at The University of Manchester, adds: “The archive manages tens of thousands of samples for a dozen diseases. Now we are using the internet to sort out the logistics of distribution.”

Simon Pullum, the chief executive of Azura Group, a technology consultancy in Essex used by the DNA Network, says: “The software is designed to be compatible with any database architecture. This will help the scientists bring in more collaborators and more data types.”

The website is at www.dna-network.ac.uk.

The UK clinicians in the Network are experts in gut, breast and white blood cell cancers, heart attacks and high blood pressure, depression, diabetes, kidney disease, multiple sclerosis, Parkinson’s and Alzheimer’s diseases, old age blindness, childhood asthma and eczema. The clinicians leading each national disease collection are based in London, Exeter, Cardiff, Oxford, Cambridge, Birmingham, Leeds, Edinburgh and Aberdeen.

Samples and data are managed at a robotic archive in the University of Manchester and in the Health Protection Agency’s European Collection of Cell Cultures labs in Salisbury.

All latest news from the category: Health and Medicine

This subject area encompasses research and studies in the field of human medicine.

Among the wide-ranging list of topics covered here are anesthesiology, anatomy, surgery, human genetics, hygiene and environmental medicine, internal medicine, neurology, pharmacology, physiology, urology and dental medicine.

Back to home

Comments (0)

Write a comment

Newest articles

Nerve cells of blind mice retain their visual function

Nerve cells in the retina were analysed at TU Wien (Vienna) using microelectrodes. They show astonishingly stable behavior – good news for retina implants. The retina is often referred to…

State-wide center for quantum science

Karlsruhe Institute of Technology joins IQST as a new partner. The mission of IQST is to further our understanding of nature and develop innovative technologies based on quantum science by…

Newly designed nanomaterial

…shows promise as antimicrobial agent. Rice scientists develop nanocrystals that kill bacteria under visible light. Newly developed halide perovskite nanocrystals (HPNCs) show potential as antimicrobial agents that are stable, effective…